Expression and analyses of the HIF-1 pathway in the lungs of humans with pulmonary arterial hypertension
Authors:
- 20 September 2016
- journal article
- research article
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 14 (5) , 4383-4390
Abstract
Spandidos Publications is a scientific publisher with a long-standing international reputation for excellent standards and high quality science publicationsKeywords
This publication has 61 references indexed in Scilit:
- Salidroside attenuates chronic hypoxia-induced pulmonary hypertension via adenosine A2a receptor related mitochondria-dependent apoptosis pathwayJournal of Molecular and Cellular Cardiology, 2015
- Elevated Plasma CXCL12α Is Associated with a Poorer Prognosis in Pulmonary Arterial HypertensionPLOS ONE, 2015
- Pro-proliferative and inflammatory signaling converge on FoxO1 transcription factor in pulmonary hypertensionNature Medicine, 2014
- HIF and pulmonary vascular responses to hypoxiaJournal of Applied Physiology, 2014
- Mechanics and Mechanisms of Pulmonary Hypertension — Conference Summary and Translational PerspectivesPulmonary Circulation, 2013
- Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2Physiological Reviews, 2012
- Overview of Current Therapeutic Approaches for Pulmonary HypertensionPulmonary Circulation, 2011
- Pulmonary Arterial HypertensionChest, 2010
- Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equationEuropean Respiratory Journal, 2009
- Pulmonary Arterial Hypertension in FranceAmerican Journal of Respiratory and Critical Care Medicine, 2006